DJ bonyf NV: bonyf appoints Ben Mettepenningen as Worldwide Enterprise Supervisor
bonyf NV bonyf NV: bonyf appoints Ben Mettepenningen as Worldwide Enterprise Supervisor 01-Jun-2022 / 18:00 CET/CEST Dissemination of a French Regulatory Information, transmitted by EQS Group. The issuer is solely answerable for the content material of this announcement.
bonyf appoints Ben Mettepenningen as Worldwide Enterprise Supervisor
Ghent (Belgium), 1 June 2022, 6.00pm; bonyf NV (Mnemonic: MLBON), the following technology oral consolation knowledgeable, proclaims the appointment of Mr. Ben Mettepenningen as Worldwide Enterprise Supervisor.
In his position, Ben Mettepenningen is answerable for the worldwide gross sales and advertising and marketing actions of the bonyf group. Ben has greater than 25 years of profitable enterprise improvement expertise, particularly, within the pharmaceutical and healthcare sectors. He has labored for prestigious worldwide firms resembling Sunstar, Dentaid, Biotene, Tradiphar (Cooper Client Well being), Nespresso and Citibank.
His experience is in gross sales, particularly, implementing new methods to extend turnover by crafting and reaching bold targets. He has a confirmed observe report within the healthcare sector, having labored for Sunstar as their Managing Director in Belgium. He then moved to Sunstar’s headquarters in Switzerland, the place he was answerable for the UK market. He was additionally appointed as European Gross sales Supervisor at Biotene. Ben has efficiently launched and relaunched a lot of oral care manufacturers, which has given him an perception into the bonyf market.
“On behalf of everybody at bonyf, I wish to welcome Ben Mettepenningen to the place of Worldwide Enterprise Supervisor. Ben brings with him a wealth of expertise. His appointment will speed up the roll-out of our revolutionary merchandise all over the world to enter new gross sales territories and enhance our market share in our present areas. Along with Ben, we’re positive to realize model recognition within the oral and wound care sector in not solely Europe but additionally globally,” says Jean-Pierre Bogaert, Founder and CEO of bonyf.
What had been your causes for becoming a member of bonyf after an intensive profession with bigger teams?
Ben Mettepenningen: “bonyf is an organization that provides motivating challenges for a gross sales particular person. bonyf’s revolutionary oral merchandise are in step with the holistic oral care method and have the potential to change into leaders on cabinets of pharmacies and supermarkets. Since its creation, bonyf has centered on growing revolutionary and patented formulations that can be utilized in numerous functions. This ensures excessive gross sales volumes may be achieved with future prospects. On the similar time, the technique of selling oral consolation with much less reliance on petrochemicals is a dedication I absolutely embrace.”
What are your high priorities for the approaching months?
Ben Mettepenningen: “bonyf is an organization with quite a lot of enterprise enlargement potential. There are a selection of key developments I bear in mind, all of that are equally essential. If I must slim it right down to solely two, I’d firstly say the penetration of additional key markets in Europe and the US. These extremely aggressive markets current fascinating alternatives for an revolutionary firm resembling bonyf for his or her star merchandise, OlivaFix Gold® and PerioTabs®, as each merchandise have clear aggressive benefits over what already exists out there. bonyf’s star merchandise usually are not but sufficiently acknowledged by prospects in these markets, while in South-East Asia, we’re getting ready to buying 2 new main pharmaceutical prospects. Secondly, bonyf’s R&D division, and its a long time of manufacturing experience, has the capability to develop its gross sales past their own-branded merchandise and into the non-public label sector. That is an space, I imagine, that may put bonyf on the map as a significant participant globally for oral and wound care merchandise.”
bonyf’s strengths . Merchandise with patented formulations . Produced in Switzerland compliant with stringent worldwide high quality rules . Confirmed scientific efficacy . Industrial presence in 36 nations . Prospects for strong development and fast profitability . A quick-growing oral and dental care market
Included in 1979, bonyf specialises within the improvement, manufacturing and promoting of cutting-edge oral & dental care merchandise. Via its unwavering dedication to innovation and steady enchancment, bonyf makes an actual distinction to individuals affected by dental and oral situations. The Firm has its R&D services in Liechtenstein (within the renown dental valley), a manufacturing plant in Switzerland and distributes its product vary in 36 nations worldwide. Benefiting from seven patent protected formulations and merchandise developed in-house, bonyf expects robust future improvement, pushed by the fast-growing oral and dental care market.
Be taught extra at https://bonyf.com
bonyf Press Relations
Jean-Pierre Bogaert CapValue
+33 1 80 81 50 00
Regulatory submitting PDF file File: bonyf appoints Ben Mettepenningen as Worldwide Enterprise Supervisor
=---------------------------------------------------- Language: English Firm: bonyf NV Doornzelestraat 114 D 9000 Gent Belgium Telephone: +41 79 412 42 79 E-mail: firstname.lastname@example.org Web: www.bonyf.com ISIN: BE6333353298 Euronext Ticker: MLBON AMF Class: Inside data / Different releases EQS Information ID: 1366555 Finish of Announcement EQS Information Service =------------------------------------------------------------------------------------
1366555 01-Jun-2022 CET/CEST
Picture hyperlink: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1366555&application_name=information
(END) Dow Jones Newswires
June 01, 2022 12:00 ET (16:00 GMT)